MCP
GH icon

Meridiem Capital Partners’s Guardant Health GH Stock Holding History

Meridiem Capital Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
+97,088
New +$10.6M 0.65% 62
2025
Q4 		– Sell
-36,681
Closed -$2.29M – 86
2025
Q3 		$2.29M Sell
36,681
-14,101
-28% -$767K 0.15% 64
2025
Q2 		$2.64M Buy
+50,782
New +$2.27M 0.19% 65

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Meridiem Capital Partners's GH Position: Q2 2026 in Review

Meridiem Capital Partners opened a new position in Guardant Health (GH) in Q2 2026: 97,088 shares worth $14.6M. The stake represents 0.65% of the portfolio and ranks #62 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in GH as recently as Q3 2025.

Meridiem Capital Partners first reported a position in GH in Q2 2025 and has held it in 3 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Meridiem Capital Partners held 97,088 shares of Guardant Health worth $14.6M as of Q2 2026.
  • Guardant Health was a new Meridiem Capital Partners position in Q2 2026.
  • Guardant Health made up 0.65% of Meridiem Capital Partners's portfolio in Q2 2026, its #62 holding.
  • Meridiem Capital Partners first reported a position in Guardant Health in Q2 2025 and has held it in 3 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.